Alcohol Dependence

关注
Scientists in a lab watch rats reject alcohol bottles after tirzepatide treatment from Mounjaro, highlighting new hope for alcoholism therapy.
AI 生成的图像

New study offers hope for weight loss drugs against alcoholism

由 AI 报道 AI 生成的图像

A new study from the University of Gothenburg shows that tirzepatide, the active ingredient in the diabetes and weight loss drug Mounjaro, reduces alcohol intake and relapse-like behaviors in rats and mice. This builds on prior research on semaglutide in Ozempic and Wegovy, which curbs alcohol consumption in humans. Researchers hope for similar effects in patients with alcohol dependence.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝